Article
U.S. FDA approves Mirati's lung cancer drug
Rating:
0.0
Views:
62
Likes:
1
Library:
1
The U.S. Food and Drug Administration approved Mirati Therapeutics Inc's lung cancer drug adagrasib, the company said on Monday, sending its shares up more than 8% in extended trading.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value